These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8479375)

  • 1. Erythromycin-associated cholestatic hepatitis.
    Derby LE; Jick H; Henry DA; Dean AD
    Med J Aust; 1993 May; 158(9):600-2. PubMed ID: 8479375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholestatic hepatitis associated with flucloxacillin.
    Derby LE; Jick H; Henry DA; Dean AD
    Med J Aust; 1993 May; 158(9):596-600. PubMed ID: 8479374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cholestatic hepatitis caused by erythromycin propionate].
    de Escalante B; Sampedro JA; Zabala S; Gracia P
    An Med Interna; 1990 Dec; 7(12):656. PubMed ID: 2135589
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholestatic hepatitis from erythromycin ethylsuccinate. Report of two cases.
    Diehl AM; Latham P; Boitnott JK; Mann J; Maddrey WC
    Am J Med; 1984 May; 76(5):931-4. PubMed ID: 6609640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cholestatic hepatitis caused by erythromycin estolate].
    García Monzón C; Noguerado A; Hidalgo S; Escudero V
    Rev Clin Esp; 1985 Nov; 177(8):420-1. PubMed ID: 3836470
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cholestasis hepatitis caused by erythromycin propionate].
    Ortuño JA; Olaso V; Berenguer J
    Med Clin (Barc); 1984 May; 82(20):912. PubMed ID: 6748800
    [No Abstract]   [Full Text] [Related]  

  • 7. [Liver damage during erythromycin therapy in 3 children].
    Buchanec J; Krajnák V
    Cesk Pediatr; 1974 Feb; 29(2):76-8. PubMed ID: 4452168
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatitis caused by various derivatives of erythromycin].
    Funck-Brentano C; Pessayre D; Benhamou JP
    Gastroenterol Clin Biol; 1983 Apr; 7(4):362-9. PubMed ID: 6347792
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolonged cholestasis and disappearance of interlobular bile ducts following chlorpropamide and erythromycin ethylsuccinate. Case of drug interaction?
    Geubel AP; Nakad A; Rahier J; Dive C
    Liver; 1988 Dec; 8(6):350-3. PubMed ID: 3265170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cholestatic hepatitis caused by midecamycin].
    Pérez Moreno JM; Saldaña González FJ; Puertas Montenegro M; Báez Perea J
    Gastroenterol Hepatol; 1996 Nov; 19(9):459-61. PubMed ID: 8998670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticlopidine-induced cholestatic hepatitis.
    Skurnik YD; Tcherniak A; Edlan K; Sthoeger Z
    Ann Pharmacother; 2003 Mar; 37(3):371-5. PubMed ID: 12639165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flucloxacillin induced delayed cholestatic hepatitis.
    Miros M; Kerlin P; Walker N; Harris O
    Aust N Z J Med; 1990 Jun; 20(3):251-3. PubMed ID: 2372276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydralazine-induced cholestatic hepatitis.
    Hassan A; Hammad R; Cucco R; Niranjan S
    Am J Ther; 2009; 16(4):371-3. PubMed ID: 19092641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ticlopidine-induced severe cholestatic hepatitis.
    Wu MS; Chan P; Lien GS; Cheng YS; Pan S
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Aug; 63(8):663-6. PubMed ID: 10969455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preajmaline-induced cholestatic hepatitis].
    Pras E; Steinlauf S; Sidi Y
    Harefuah; 1991 Nov; 121(10):380-1. PubMed ID: 1752555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probable ticlopidine-induced cholestatic hepatitis.
    Cassidy LJ; Schuster BG; Halparin LS
    Ann Pharmacother; 1995 Jan; 29(1):30-2. PubMed ID: 7711343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholestatic and hepatocellular injury associated with erythromycin esters: report of nine cases.
    Zafrani ES; Ishak KG; Rudzki C
    Dig Dis Sci; 1979 May; 24(5):385-96. PubMed ID: 456225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Toxic cholestatic hepatitis due to phenytoin].
    de la Serna Higuera C; Gil Grande LA; Bárcena Marugán R
    Gastroenterol Hepatol; 1995 Nov; 18(9):471-3. PubMed ID: 8521225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinic-epidemiological significance of drug hepatotoxicity in liver disease consultation].
    Jmelnitzky AC; Guidi M; Bologna A; Viola M; Soccini C; Barbero R; Belloni P; Apraiz M
    Acta Gastroenterol Latinoam; 2000; 30(2):77-84. PubMed ID: 10925723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database.
    Russmann S; Kaye JA; Jick SS; Jick H
    Br J Clin Pharmacol; 2005 Jul; 60(1):76-82. PubMed ID: 15963097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.